Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in Chile

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: Chile Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20061
20071
20081
20093
20103
20112
20121
20132
20141
20161
20181
20193
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated4
Recruiting3
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
GlaxoSmithKline4
Takeda3
Pfizer2
Sanofi2
United Therapeutics2
Alnylam Pharmaceuticals1
Amgen1
Boehringer Ingelheim1
CSL Behring1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases27
Hypertension8
Myocardial Infarction6
Stroke6
Atherosclerosis5
Acute Coronary Syndrome4
Diabetes Mellitus, Type 24
Heart Diseases4
Vascular Diseases4
Atrial Fibrillation2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.